Delving into the Latest Updates on Suzhou Pharmavan Cancer Research Center Co., Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Cardiovascular Diseases

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	3
Immune System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	5

Top 5 Target	Count

GABAA receptor(Gamma-aminobutyric acid A receptor)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

2

1

IND Approval

Phase 1

2

1

Phase 3

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

SPT-07A ( GABAA receptor )	Acute Ischemic Stroke More	Phase 3
HY1839	Crohn Disease More	Phase 1
HY-0721	Acute Ischemic Stroke More	Phase 1
HY-1770 ( IL-17A x IL-17F x IL-4Rα )	Dermatitis, Atopic More	IND Approval
HT24	Inflammation More	Preclinical